Showing results (2001-2010 of 3,531) with videos related to

Sort By:
Pageof 354
Thoracic Cancer|March 30, 2022
Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathwayMengyuan Li, Xingjiu Yang, Guoxin Zhang, et al.
Thoracic Cancer|March 29, 2022
Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIsXinyang Du, Hua Bai, Zhijie Wang, et al.
Thoracic Cancer|March 29, 2022
Thymoma exhibiting spontaneous regression with developing myasthenia gravis: A case reportKazuhisa Nishina, Mikito Suzuki, Azusa Nakamura, et al.
Thoracic Cancer|September 25, 2018
Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathwaysYulan Yan, Sha Liu, Mi Li, et al.
Thoracic Cancer|September 26, 2018
Determination and pharmacokinetic study of AZD-3759 in rat plasma by ultra performance liquid chromatography with triple quadrupole mass spectrometerQingjun Wu, Ailian Hua, Yaoguang Sun, et al.
Thoracic Cancer|September 26, 2018
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional studyYing Cheng, Yan Wang, Jun Zhao, et al.
Thoracic Cancer|September 30, 2018
Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinomaZhongwei Xin, Xuemin Song, Bin Jiang, et al.
Thoracic Cancer|August 29, 2018
Microarray expression profile of long non-coding RNAs in human lung adenocarcinomaZhiyi Yang, Hongli Li, Zhaoyan Wang, et al.
Thoracic Cancer|August 29, 2018
Comparative effectiveness of concurrent chemoradiotherapy versus EGFR-tyrosine kinase inhibitors for the treatment of clinical stage IIIb lung adenocarcinoma patients with mutant EGFRTe-Chun Hsia, Ji-An Liang, Chia-Chin Li, et al.
Thoracic Cancer|October 9, 2018
Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case reportPing Zhang, Xin Nie, Bing Wang, et al.
Pageof 354